Key statistics
As of last trade Catalyst Pharmaceuticals Inc (CPRX:NAQ) traded at 23.13, -13.00% below its 52-week high of 26.58, set on Jun 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 22.48 |
|---|---|
| High | 23.19 |
| Low | 22.27 |
| Bid | 23.10 |
| Offer | 23.15 |
| Previous close | 23.08 |
| Average volume | 1.34m |
|---|---|
| Shares outstanding | 122.12m |
| Free float | 114.24m |
| P/E (TTM) | 13.70 |
| Market cap | 2.82bn USD |
| EPS (TTM) | 1.68 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 17:00 GMT.
More ▼
- Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance
- Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference
- Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
- Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies
- The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)
- Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
- Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™
- Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
- Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
More ▼
